32620763

Summary
Title
Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation.
Authors
  • Barbier-Torres L
  • Fortner KA
  • Iruzubieta P
  • Delgado TC
  • Giddings E
  • Chen Y
  • Champagne D
  • Fernández-Ramos D
  • Mestre D
  • Gomez-Santos B
  • Varela-Rey M
  • de Juan VG
  • Fernández-Tussy P
  • Zubiete-Franco I
  • García-Monzón C
  • González-Rodríguez Á
  • Oza D
  • Valença-Pereira F
  • Fang Q
  • Crespo J
  • Aspichueta P
  • Tremblay F
  • Christensen BC
  • Anguita J
  • Martínez-Chantar ML
  • Rincón M
Source
Nat Commun
Publication Date
2020 Jul 3
PubMed ID
32620763

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024